CEO: Sean A. McCarthy

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.


Key numbers

Market Capitalization:338937640
Shares Outstanding: 45434000
Float: 44203238
Next Earning Date:2020-03-05
TTm EPS: -2.1885
TTm Dividend Rate:
200 days moving average:8.93
50 days moving average: 6.97
One day percent Change: -0.93



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,